Latoya Gayle, MD
Nephrology · Bear, DENPI 1003301946
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.9% of the total across 37 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 13 manufacturers reported payments, led by AstraZeneca at 31.4% of the total. Reporting peaked in 2024 at $507 and has fallen 53.3% since, to $236 in 2025. That places this record below the midpoint for nephrology clinicians in DE, where the typical reported total is $2,465.
Across 37 payments — averaging $25.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$297
- Akebia Therapeutics Inc$132
- Bayer$113
- Novartis$94
- Ardelyx, Inc.$68
- Otsuka America Pharmaceutical, Inc.$52
- plus $191 from 7 others
What the payments were for
- Food & beverage$92798%
- Education$202%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 7 | $297 |
| Akebia Therapeutics Inc | 5 | $132 |
| Bayer | 6 | $113 |
| Novartis | 4 | $94 |
| Ardelyx, Inc. | 3 | $68 |
| Otsuka America Pharmaceutical, Inc. | 2 | $52 |
| Shield Therapeutics Inc | 2 | $48 |
| Calliditas Therapeutics US Inc. | 2 | $36 |
| Boehringer Ingelheim | 1 | $30 |
| Travere Therapeutics, Inc. | 2 | $23 |
| Kyowa Kirin, Inc. | 1 | $22 |
| OPKO Pharmaceuticals, LLC | 1 | $18 |
| GSK | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LOKELMA$125
How this compares
$947 in reported general payments places this provider in the 30th percentile of 49 nephrology providers in Delaware.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Potassium Citrate ErPotassium Citrate | 26 | $2,229 |
| Amlodipine Besylate | 224 | $1,881 |
| Calcitriol | 79 | $1,517 |
| Losartan Potassium | 115 | $1,282 |
| Potassium Chloride | 27 | $1,175 |
| Hydralazine Hcl | 51 | $1,007 |
| Metoprolol Succinate | 63 | $915 |
| Lisinopril | 88 | $739 |
| Labetalol Hcl | 11 | $580 |
| Carvedilol | 64 | $549 |
| Furosemide | 99 | $549 |
| Fludrocortisone Acetate | 18 | $509 |
| Amlodipine-ValsartanAmlodipine Besylate/Valsartan | 12 | $471 |
| Clonidine Hcl | 24 | $460 |
| Triamterene-HydrochlorothiazidTriamterene/Hydrochlorothiazid | 25 | $429 |
Paid to pharmacies, not to this prescriber.
Other nephrology in Bear
- Jose CabralesBear$1K
- Prayus TailorNewark$127K
- William DahmsNewark$94K
- Theodore SaadNewark$26K
- Gerald MilanDover$16K
- Ranine GhamrawiWilmington$16K
- Arun MalhotraWilmington$9K
- Gertrude Findley-ChristianDover$8K
- Sumanth KacharamDover$7K
- Sangeetha SatyanDover$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.